Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE study
Aim: Lercanidipine, a long-acting dihydropyridine with a good antihypertensive efficacy and
tolerability in clinical use. With the aim to determine the efficacy and tolerability of this drug in …
tolerability in clinical use. With the aim to determine the efficacy and tolerability of this drug in …
Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension
R Agrawal, A Marx, H Haller - Journal of hypertension, 2006 - journals.lww.com
Objective Angiotensin-converting enzyme inhibitors plus dihydropyridine calcium channel
blockers or low-dose thiazide diuretics are considered first-line therapies in hypertensive …
blockers or low-dose thiazide diuretics are considered first-line therapies in hypertensive …
Cardiovascular safety of lercanidipine in patients with angina pectoris: a review of six randomized clinical trials
G Specchia, SP Saccaggi, C Ghezzi - Current therapeutic research, 2001 - Elsevier
Background: Lercanidipine, a novel lipophilic and vasoselective dihydropyridine calcium
antagonist, is an effective antihypertensive drug at dosages of 10 mg once daily in most …
antagonist, is an effective antihypertensive drug at dosages of 10 mg once daily in most …
The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats
The pathogenesis of diabetic neuropathy is a complex phenomenon, the mechanisms of
which are not fully understood. Our previous studies have shown that the intracellular …
which are not fully understood. Our previous studies have shown that the intracellular …
A randomized, double-blind comparison of 10 and 20 mg lercanidipine in patients with stable effort angina: effects on myocardial ischemia and heart rate variability
D Acanfora, L Trojano, M Gheorghiade… - American journal of …, 2002 - journals.lww.com
We evaluated the anti-ischemic action and the effects on autonomic function of
lercanidipine, a long-acting dihydropyridine calcium antagonist, in 25 patients with stable …
lercanidipine, a long-acting dihydropyridine calcium antagonist, in 25 patients with stable …
A randomized, double-blind comparison of lercanidipine 10 and 20 mg in patients with stable effort angina: clinical evaluation of cardiac function by ambulatory …
D Acanfora, M Gheorghiade, L Trojano… - American journal of …, 2004 - journals.lww.com
We evaluated the antiischemic action and the effects on left ventricular response to exercise
of lercanidipine, a long-acting dihydropyridine calcium antagonist, in 23 patients with stable …
of lercanidipine, a long-acting dihydropyridine calcium antagonist, in 23 patients with stable …
The pharmacological differences in antianginal effects of long-lasting calcium channel blockers: azelnidipine and amlodipine
M Fujisawa, R Yorikane, Y Matsuoka… - Journal of …, 2013 - journals.lww.com
We examined antianginal effects of azelnidipine and amlodipine in an arginine vasopressin–
induced rat anginal model. Oral administration of azelnidipine or amlodipine produced long …
induced rat anginal model. Oral administration of azelnidipine or amlodipine produced long …
Amlodipine as an antiischemic drug is superior to long acting nitrates
GP Koraćević, SS Dakić… - Open …, 2015 - degruyter.com
Abstract European Society of Cardiology Guidelines cite results of meta-analysis that the
use of calcium channel blockers results in fewer angina episodes per week vs. long-acting …
use of calcium channel blockers results in fewer angina episodes per week vs. long-acting …
Pharma clinics. Le médicament du mois. La lercanidipine (Zanidip)
JM Krzesinski - Revue Médicale de Liège, 1999 - orbi.uliege.be
La lercanidipine (Zanidip8) est un nouvel inhibiteur caldque de la famille des
dihydropyridines qui se positionne dans le traitement de l'hypertension artérielle. Son …
dihydropyridines qui se positionne dans le traitement de l'hypertension artérielle. Son …
Efectividad antihipertensiva y tolerabilidad de lercanidipino en diabéticos, en pacientes con hipertensión sistólica aislada y en ancianos. Análisis de subgrupos del …
VB Alonso, JPT Zarlenga, AN Lima, AE Sierra… - Hipertensión y riesgo …, 2003 - Elsevier
El estudio ELYPSE, recientemente publicado, es un estudio de farmacovigilancia que
analizó la eficacia y tolerabilidad de lercanidipino (10 mg una vez al día) en 9.059 pacientes …
analizó la eficacia y tolerabilidad de lercanidipino (10 mg una vez al día) en 9.059 pacientes …